GlassScriptPhysician profile
Ravi Makwana
NPI 1174732861
$1,619.47
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,195 · 2020: $195 · 2021: $145 · 2022: $85.15.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $281.49 | 2019-2021 | |
| Lilly USA, LLC | $219.04 | 2019-2021 | |
| Novo Nordisk INC | $196.17 | 2019-2022 | |
| Eisai INC. | $124.45 | 2019 | |
| Amarin Pharma, INC. | $114.97 | 2019-2021 | |
| Amgen INC. | $113.87 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.84 | 2019 | |
| Pfizer INC. | $74.24 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.57 | 2019-2021 | |
| Astellas Pharma US INC | $57.88 | 2019-2020 | |
| Allergan, INC. | $37.88 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $36.06 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.15 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.60 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.47 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $22.42 | 2022 | |
| Lundbeck LLC | $18.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.73 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.90 | 2021 | |
| Sanofi Pasteur INC. | $15.87 | 2019 | |
| Abbott Laboratories | $13.36 | 2021 | |
| Glaxosmithkline, LLC. | $11.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Makwana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.